UK Votes To Leave The EU – Where Next For The Life Sciences?
Executive Summary
UK vote to leave the EU opens the prospect of years of negotiations over the union's future relationship with one of its most valued member states.
You may also be interested in...
J&J's Siegel On Brexit: 'Our Objective Is To Minimize Any Disruption'
J&J's head of scientific strategy and policy says in an interview that the two-year withdrawal timeline for the UK to leave the EU 'hopefully' provides the firm 'enough time to ensure continuity of business.'
FDA Winging It With Brexit: Califf Says Agency Will React To What Happens
Commissioner says his agency does not have a plan to deal with UK's departure from the EU.
European Notebook: UK To Leave EU; Prices Attract Political Attention; Advanced Therapies Revamp
Brexit vote creates uncertainty about biopharma policies in the UK and how local companies interact with the rest of the world;; antibiotic use decreases in several countries; high prices prompt European Commission review of industry incentives.